Quantcast

Posts related to ‘Healthcare’

Johnson & Johnson Logo

J&J Shareholders Should Expect Higher Dividend Next Week

Johnson & Johnson (NYSE: JNJ) managed to beat earnings expectations this morning, and the drug and consumer products giant also reaffirmed its earnings guidance for 2013. This morning we noted ...
Read Full Story »
76764023

VIVUS FDA Approval of Qsymia Expands the Obesity Customer Base

VIVUS, Inc. (NASDAQ: VVUS) has just secured Food and Drug Administration  approval of an amendment and modification to the Risk Evaluation and Mitigation Strategy for its weight-loss drug Qsymia. With ...
Read Full Story »
Johnson & Johnson Logo

J&J Manages to Beat Earnings Despite Currency Drag

Johnson & Johnson (NYSE: JNJ) has now reported its first-quarter results, showing an 8.5% gain in sales to $17.5 billion, and earnings of $4.1 billion on a normalized earnings basis ...
Read Full Story »
biotech

Gene Patent Showdown for Myriad Comes to a Head

Should a company get to patent your genetic DNA? That is the question when it comes to Myriad Genetics Inc. (NASDAQ: MYGN). This company and its stock are at the ...
Read Full Story »
76764023

America’s Fattest Cities

Obesity may be the most closely followed health care issue in the United States. The rate of obesity has increased dramatically in the past two decades, growing from 13% in ...
Read Full Story »
pills

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

With the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or ...
Read Full Story »
153576724

America’s Most Obese Cities

America's least obese cities are Boulder; Charlottesville, Va.; Bellingham Wash.; Fort Collins, Colo.; Naples, Fla.; Denver; San Francisco; San Lois Obisco; Madison, Wisc.; and Colorado Springs. Many of these cities ...
Read Full Story »
health care

More Worries About Boston Scientific Turnaround Story

24/7 Wall St. recently featured the waves of the most promising turnarounds for 2013. It was amazing to see some of the battered yet recovered stocks on that list. Some ...
Read Full Story »
Bull and Bear

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (CELG, CMCSA, FB, FFIV, JPM, JNPR, KMB, NWSA, PDCE, AET, CI, HUM, UNH, WLP)

Investors and traders are usually on the hunt for new ideas that will generate positive returns or income. 24/7 Wall St. looks over numerous research calls to find great ideas ...
Read Full Story »
76764023

How the U.S. Is Making the Rest of the World Fat

People who live in nations where most residents were thin, at least as measured against the tremendous number of obese Americans, are getting fatter. Bloomberg blames this, in part, on ...
Read Full Story »
Stock Split Image

Boston Scientific Downgrade — Valuation or Turnaround Risk?

Boston Scientific Corp. (NYSE: BSX) is in a long-term turnaround that frankly just feels like it never really has turned around. Or has it? We can criticize the mistakes of ...
Read Full Story »
health care

What Medicare Reimbursement Increases Really Mean (AET, CI, HUM, UNH, WLP, UAM)

After promising voters that the Affordable Healthcare Act (aka Obamacare), and other health care initiatives designed by the current administration would not result in any increase in costs for citizens, ...
Read Full Story »
biotech

Top Biotech-Pharma Stock Ideas with Continued Big Upside (OREX, HALO, BAX, BMRN)

Much of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable ...
Read Full Story »
biotech

Another Major MS Approval Keeps Driving Biogen Idec

Shares of Biogen Idec Inc. (NASDAQ: BIIB) did not just do well on Wednesday. The stock hit an all-time high. News hit late in the day that the U.S. Food ...
Read Full Story »